Short Interest in Microbot Medical Inc. (NASDAQ:MBOT) Expands By 131.7%

Microbot Medical Inc. (NASDAQ:MBOT) was the recipient of a significant increase in short interest during the month of January. As of January 31st, there was short interest totalling 4,170,000 shares, an increase of 131.7% from the January 15th total of 1,800,000 shares. Based on an average daily trading volume, of 3,360,000 shares, the short-interest ratio is currently 1.2 days.

Analysts Set New Price Targets

Separately, HC Wainwright upped their target price on Microbot Medical from $7.00 to $9.00 and gave the company a “buy” rating in a research report on Friday, January 24th.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Microbot Medical stock. Geode Capital Management LLC raised its stake in Microbot Medical Inc. (NASDAQ:MBOT) by 7.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 142,659 shares of the biotechnology company’s stock after acquiring an additional 10,442 shares during the quarter. Geode Capital Management LLC owned approximately 0.70% of Microbot Medical worth $160,000 at the end of the most recent reporting period. 16.30% of the stock is owned by institutional investors and hedge funds.

Microbot Medical Price Performance

NASDAQ:MBOT traded down $0.07 during trading hours on Thursday, reaching $2.09. The company had a trading volume of 1,713,606 shares, compared to its average volume of 7,133,299. Microbot Medical has a 1-year low of $0.82 and a 1-year high of $3.38. The firm has a market cap of $42.20 million, a PE ratio of -2.61 and a beta of 1.51. The business’s 50 day moving average price is $1.59 and its 200-day moving average price is $1.17.

Microbot Medical Company Profile

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.